Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC has started to provide services to pharmaceutical companies on hospital and med tech reimbursement

MTRC is expanding its service offering to pharma companies. The scope of the services includes reimbursement analysis and strategy for hospital (high cost) drugs, cell and gene therapies, companion diagnostics, drug delivery systems and e-health solutions. 

MTRC is uniquely positioned to support pharmaceutical companies in the market access areas, difficult for typical pharma consultancies because of its extensive expertise with hospital (DRG) and day case payment systems, coding rules at the hospital level, payment systems for IVD tests in hospital and ambulatory segments, payment systems for drug-delivery solutions in hospital, day case, ambulatory and home settings and reimbursement frameworks for e-health solutions

Learn more at our new web-site dedicated to the support to pharma companies: